Fastbom, Johan
Jonasdottir Bergman, Gudrun
Holm, Johanna
Hanberger, Håkan
Strålin, Kristoffer
Walther, Sten
Alfredsson, Joakim
State, Maria
Borg, Natalia
Nyman Iliadou, Anastasia
Funding for this research was provided by:
Karolinska Institute
Article History
Received: 9 April 2024
Accepted: 3 June 2024
First Online: 24 June 2024
Declarations
:
: This study was approved by the Regional ethics review board in Uppsala (Dnr 2020–04278).
: All data in the Swedish National Prescribed Drug Register are recorded without written consent from the patients.
: J.F. is an Advisory Editor for the European Journal of Clinical Pharmacology. J.A. has served on advisory boards for AstraZeneca, Bayer, MSD and Novartis, and received lecture fees from AstraZeneca, Bayer, Boehringer Ingelheim and Novartis, unrelated to this work. All other authors declare no competing interests.